Fields »
ABOUT
HELP
BLOG

556 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 12 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
BCHEButyrylcholinesteraseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
BCL2B-cell CLL/lymphoma 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Nuclear membrane		Tissue enhanced
BCRBreakpoint cluster regionCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol		Expressed in all
BDKRB2Bradykinin receptor B2FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
BGLAPBone gamma-carboxyglutamate (gla) proteinFDA approved drug targets
Predicted secreted proteins
Mixed
BLVRBBiliverdin reductase BEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Nucleoplasm
Plasma membrane
Cytosol		Expressed in all
BRAFB-Raf proto-oncogene, serine/threonine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Vesicles
Cytosol		Expressed in all
BTKBruton agammaglobulinemia tyrosine kinaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
VesiclesTissue enhanced
CA1Carbonic anhydrase IEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Group enriched
CA14Carbonic anhydrase XIVEnzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
CA2Carbonic anhydrase IIDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enhanced
CA3Carbonic anhydrase IIIEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
CA4Carbonic anhydrase IVDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
CA7Carbonic anhydrase VIIEnzymes
FDA approved drug targets
Predicted intracellular proteins
Tissue enhanced
CACNA1ACalcium channel, voltage-dependent, P/Q type, alpha 1A subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Vesicles		Tissue enhanced
CACNA1BCalcium channel, voltage-dependent, N type, alpha 1B subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Group enriched
CACNA1CCalcium channel, voltage-dependent, L type, alpha 1C subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
CACNA1DCalcium channel, voltage-dependent, L type, alpha 1D subunitCancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Nuclear membraneMixed
CACNA1FCalcium channel, voltage-dependent, L type, alpha 1F subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
CACNA1GCalcium channel, voltage-dependent, T type, alpha 1G subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1HCalcium channel, voltage-dependent, T type, alpha 1H subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Vesicles		Tissue enhanced
CACNA1ICalcium channel, voltage-dependent, T type, alpha 1I subunitFDA approved drug targets
Plasma proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
CACNA1SCalcium channel, voltage-dependent, L type, alpha 1S subunitDisease related genes
FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Tissue enriched
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Mixed
CACNA2D2Calcium channel, voltage-dependent, alpha 2/delta subunit 2FDA approved drug targets
Predicted intracellular proteins
Transporters
VesiclesTissue enriched
CACNB1Calcium channel, voltage-dependent, beta 1 subunitFDA approved drug targets
Predicted intracellular proteins
Group enriched
CACNB2Calcium channel, voltage-dependent, beta 2 subunitDisease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
Mixed
CACNB3Calcium channel, voltage-dependent, beta 3 subunitFDA approved drug targets
Predicted intracellular proteins
Transporters
Golgi apparatus
Vesicles		Mixed
CACNB4Calcium channel, voltage-dependent, beta 4 subunitDisease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Tissue enhanced
CACNG1Calcium channel, voltage-dependent, gamma subunit 1FDA approved drug targets
Predicted membrane proteins
Transporters
Tissue enriched
CALYCalcyon neuron-specific vesicular proteinFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
CAMLGCalcium modulating ligandFDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleus
Nucleoli
Vesicles		Expressed in all
CARTPTCART prepropeptideFDA approved drug targets
Predicted secreted proteins
Tissue enriched
CASRCalcium-sensing receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
CATCatalaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Vesicles
Cytosol		Expressed in all
CCKARCholecystokinin A receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Group enriched
CCKBRCholecystokinin B receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Group enriched
CCL2Chemokine (C-C motif) ligand 2Cancer-related genes
Candidate cardiovascular disease genes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Golgi apparatus
Vesicles		Expressed in all
CCND1Cyclin D1Cancer-related genes
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
NucleoplasmTissue enhanced
CCR5Chemokine (C-C motif) receptor 5 (gene/pseudogene)CD markers
Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
CD44CD44 molecule (Indian blood group)Blood group antigen proteins
Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane		Expressed in all
CDK4Cyclin-dependent kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleus
Nuclear membrane
Nucleoli
Cytosol		Expressed in all
CDK6Cyclin-dependent kinase 6Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Cytosol		Mixed
CES1Carboxylesterase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Endoplasmic reticulumGroup enriched
CFTRCystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
CHD1Chromodomain helicase DNA binding protein 1Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center		Expressed in all
CHRM1Cholinergic receptor, muscarinic 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Cytosol		Group enriched
CHRM2Cholinergic receptor, muscarinic 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
CHRM3Cholinergic receptor, muscarinic 3Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Plasma membraneTissue enhanced
CHRM4Cholinergic receptor, muscarinic 4FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Nucleus
Golgi apparatus		Tissue enhanced

« prev | Page of 12 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.